HuGE Literature Finder
|
||
Records 1-30
|
[Mutation analysis of 77 patients with normal-karyotype myelodysplastic syndrome].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 Sep 36 (9): 857-861. Qin Wei, Chen Meiyu, Cai Xiaohui, Chao Hongying, Liu Jie, Jiang Naike, Zhou Min, Lu Xuzhang, Chen Suning, Zhang Ri, He Chuan, Wang Qi |
|
The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly-annotated patients with primary myelofibrosis.
American journal of hematology 2019 Mar 94 (3): 299-305. Tefferi Ayalew, Lasho Terra L, Mudireddy Mythri, Finke Christy M, Hanson Curtis A, Ketterling Rhett P, Gangat Naseema, Pardanani Anime |
|
Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors.
Medical oncology (Northwood, London, England) 2018 Aug 35 (9): 119. Helbig Grzego |
|
Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis.
Clinical lymphoma, myeloma & leukemia 2018 Jun . Lee Yen-Chien, Hsieh Chung-Cheng, Lee Yen-Ling, Li Chung- |
|
ASXL1 mutations in Chinese patients with essential thrombocythemia.
Experimental and therapeutic medicine 2018 May 15 (5): 4149-4156. Nie Yan-Bo, Sun Meng, He Colin K, Ju Man-Kai, Zhou Fu-Ling, Wu San-Yun, Zhou Yi, Liu Li, Shen Hui, Huang Ting-Ting, Liu Pan, Xu Ying, Shao Liang, Zuo Xue-L |
|
Selected Parameters of Angiogenesis and the JAK2, CALR, and MPL Mutations in Patients With Essential Thrombocythemia.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2018 Jan 1076029617740222. Gadomska Gra?yna, Bartoszewska-Kubiak Alicja, Boinska Joanna, Matiakowska Karolina, Zio?kowska Katarzyna, Haus Olga, Ro?? Danu |
|
Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center.
Neoplasma 2018 65 (2): 296-303. Palova M, Szotkowski T, Hlusi A, Indrak K, Navratilova J, Divoka M, Papajik |
|
The clinical and prognostic relevance of driver mutations in 203 Taiwanese patients with primary myelofibrosis.
Journal of clinical pathology 2017 Dec . Kuo Ming-Chung, Lin Tung-Huei, Sun Chien-Feng, Lin Tung-Liang, Wu Jin-Hou, Wang Po-Nan, Huang Ying-Jung, Chang Hung, Huang Ting-Yu, Shih Lee-Yu |
|
Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients.
American journal of hematology 2017 Nov . Tefferi Ayalew, Nicolosi Maura, Mudireddy Mythri, Szuber Natasha, Finke Christy M, Lasho Terra L, Hanson Curtis A, Ketterling Rhett P, Pardanani Animesh, Gangat Naseema, Mannarelli Carmela, Fanelli Tiziana, Guglielmelli Paola, Vannucchi Alessandro |
|
JAK2, MPL, and CALR mutations in Chinese Han patients with essential thrombocythemia.
Hematology (Amsterdam, Netherlands) 2017 Apr 22 (3): 145-148. Wang Jing, Zhang Biao, Chen Bing, Zhou Rong-Fu, Zhang Qi-Guo, Li Juan, Yang Yong-Gong, Zhou Min, Shao Xiao-Yan, Xu Yong, Xu Xi-Hui, Ouyang Jian, Xu Jingyan, Ye Qi |
|
[The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2017 Jan 38 (1): 28-32. Cui Y J, Jiang Q, Liu J Q, Li B, Xu Z F, Qin T J, Zhang Y, Cai W Y, Zhang H L, Fang L W, Pan L J, Hu N B, Qu S Q, Xiao Z |
|
Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia.
British journal of haematology 2017 09 178 (5): 764-771. Alvarez-Larrán Alberto, Senín Alicia, Fernández-Rodríguez Concepción, Pereira Arturo, Arellano-Rodrigo Eduardo, Gómez Montse, Ferrer-Marin Francisca, Martínez-López Joaquín, Camacho Laura, Colomer Dolors, Angona Anna, Navarro Blanca, Cervantes Francisco, Besses Carlos, Bellosillo Beatriz, Hernández-Boluda Juan Carl |
|
Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing.
American journal of clinical pathology 2016 Oct 146 (4): 448-55. Gardner Juli-Anne, Peterson Jason D, Turner Scott A, Soares Barbara L, Lancor Courtney R, Dos Santos Luciana L, Kaur Prabhjot, Ornstein Deborah L, Tsongalis Gregory J, de Abreu Francine |
|
Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.
Annals of hematology 2016 Sep . Kourie Hampig Raphael, Ameye Lieveke, Paesmans Marianne, Bron Dominiq |
|
Simultaneous screening for JAK2 and calreticulin gene mutations in myeloproliferative neoplasms with high resolution melting.
Clinica chimica acta; international journal of clinical chemistry 2016 Sep 462 166-173. Matsumoto Nariyoshi, Mori Sayaka, Hasegawa Hiroo, Sasaki Daisuke, Mori Hayato, Tsuruda Kazuto, Imanishi Daisuke, Imaizumi Yoshitaka, Hata Tomoko, Kaku Norihito, Kosai Kousuke, Uno Naoki, Miyazaki Yasushi, Yanagihara Katsuno |
|
Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.
Annals of hematology 2016 Jul . Pei Yu-Qing, Wu Yue, Wang Fei, Cui W |
|
Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosis.
British journal of haematology 2016 Jun . Beauverd Yan, Alimam Samah, McLornan Donal P, Radia Deepti H, Harrison Claire |
|
Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemia.
American journal of hematology 2016 May 91 (5): 503-6. Elala Yoseph C, Lasho Terra L, Gangat Naseema, Finke Christy, Barraco Daniela, Haider Mahnur, Abou Hussein Ahmed K, Hanson Curtis A, Ketterling Rhett P, Pardanani Animesh, Tefferi Ayal |
|
Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis.
Clinical lymphoma, myeloma & leukemia 2016 Feb . Kourie Hampig Raphael, Ameye Lieveke, Paesmans Marianne, Bron Dominiq |
|
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.
Leukemia 2015 Oct . Pietra D, Rumi E, Ferretti V V, Di Buduo C A, Milanesi C, Cavalloni C, Sant'Antonio E, Abbonante V, Moccia F, Casetti I C, Bellini M, Renna M C, Roncoroni E, Fugazza E, Astori C, Boveri E, Rosti V, Barosi G, Balduini A, Cazzola |
|
Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations.
Haematologica 2015 Jul 100 (7): 893-7. Al Assaf Carla, Van Obbergh Florence, Billiet Johan, Lierman Els, Devos Timothy, Graux Carlos, Hervent Anne-Sophie, Emmerechts Jan, Tousseyn Thomas, De Paepe Pascale, Papadopoulos Petros, Michaux Lucienne, Vandenberghe Pet |
|
JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis.
Journal of Korean medical science 2015 Jul 30 (7): 882-8. Kim Bo Hyun, Cho Young-Uk, Bae Mi-Hyun, Jang Seongsoo, Seo Eul-Ju, Chi Hyun-Sook, Choi Yunsuk, Kim Dae-Young, Lee Jung-Hee, Lee Je-Hwan, Lee Kyoo-Hyung, Park Young-Mi, Lee Jong-Keuk, Park Chan-Jeou |
|
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.
Leukemia 2015 Jun 29 (6): 1344-9. Palandri F, Latagliata R, Polverelli N, Tieghi A, Crugnola M, Martino B, Perricone M, Breccia M, Ottaviani E, Testoni N, Merli F, Aversa F, Alimena G, Cavo M, Martinelli G, Catani L, Baccarani M, Vianelli |
|
Calreticulin exon 9 mutations in myeloproliferative neoplasms.
Annals of laboratory medicine 2015 Jan 35 (1): 22-7. Ha Jung-Sook, Kim Yu-Kyu |
|
CALR mutation screening in pediatric primary myelofibrosis.
Pediatric blood & cancer 2014 Dec 61 (12): 2256-62. An Wenbin, Wan Yang, Guo Ye, Chen Xiaojuan, Ren Yuanyuan, Zhang Jingliao, Chang Lixian, Wei Wei, Zhang Peihong, Zhu Xiaof |
|
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis.
Blood 2014 Oct 124 (16): 2507-13; quiz 2615. Tefferi Ayalew, Guglielmelli Paola, Larson Dirk R, Finke Christy, Wassie Emnet A, Pieri Lisa, Gangat Naseema, Fjerza Rajmonda, Belachew Alem A, Lasho Terra L, Ketterling Rhett P, Hanson Curtis A, Rambaldi Alessandro, Finazzi Guido, Thiele Juergen, Barbui Tiziano, Pardanani Animesh, Vannucchi Alessandro |
|
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.
Blood 2014 Aug 124 (7): 1062-9. Rumi Elisa, Pietra Daniela, Pascutto Cristiana, Guglielmelli Paola, Martínez-Trillos Alejandra, Casetti Ilaria, Colomer Dolors, Pieri Lisa, Pratcorona Marta, Rotunno Giada, Sant'Antonio Emanuela, Bellini Marta, Cavalloni Chiara, Mannarelli Carmela, Milanesi Chiara, Boveri Emanuela, Ferretti Virginia, Astori Cesare, Rosti Vittorio, Cervantes Francisco, Barosi Giovanni, Vannucchi Alessandro M, Cazzola Mario, |
|
Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients.
American journal of hematology 2014 Aug 89 (8): E121-4. Tefferi Ayalew, Wassie Emnet A, Guglielmelli Paola, Gangat Naseema, Belachew Alem A, Lasho Terra L, Finke Christy, Ketterling Rhett P, Hanson Curtis A, Pardanani Animesh, Wolanskyj Alexandra P, Maffioli Margherita, Casalone Rosario, Pacilli Annalisa, Vannucchi Alessandro M, Passamonti Frances |
|
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.
Blood 2014 Apr 123 (14): 2220-8. Lundberg Pontus, Karow Axel, Nienhold Ronny, Looser Renate, Hao-Shen Hui, Nissen Ina, Girsberger Sabine, Lehmann Thomas, Passweg Jakob, Stern Martin, Beisel Christian, Kralovics Robert, Skoda Radek |
|
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
The New England journal of medicine 2013 Dec 369 (25): 2391-405. Nangalia J, Massie C E, Baxter E J, Nice F L, Gundem G, Wedge D C, Avezov E, Li J, Kollmann K, Kent D G, Aziz A, Godfrey A L, Hinton J, Martincorena I, Van Loo P, Jones A V, Guglielmelli P, Tarpey P, Harding H P, Fitzpatrick J D, Goudie C T, Ortmann C A, Loughran S J, Raine K, Jones D R, Butler A P, Teague J W, O'Meara S, McLaren S, Bianchi M, Silber Y, Dimitropoulou D, Bloxham D, Mudie L, Maddison M, Robinson B, Keohane C, Maclean C, Hill K, Orchard K, Tauro S, Du M-Q, Greaves M, Bowen D, Huntly B J P, Harrison C N, Cross N C P, Ron D, Vannucchi A M, Papaemmanuil E, Campbell P J, Green A |
- Page last reviewed:Jul 30, 2019
- Page last updated:Nov 14, 2019
- Content source: